Increased transcript level of poly(ADP-ribose) polymerase (PARP-1) in human tricuspid compared with bicuspid aortic valves correlates with the stenosis severity

Biochemical and Biophysical Research Communications

Volumn 420, Issue 3, 2012, Pages 671-675

  Nagy, Edit ^a,b   Caidahl, Kenneth ^a,b   Franco Cereceda, Anders ^a,b   Bäck, Magnus ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Aortic valve stenosis; Cytokines; Echocardiography; Inflammation; Valvular interstitial cells

Indexed keywords

CYTOKINE; LEUKOTRIENE C4; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1;

ADULT; AGED; AORTA VALVE REPLACEMENT; ARTICLE; BICUSPID AORTIC VALVE; BODY SURFACE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEMODYNAMIC PARAMETERS; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; QUANTITATIVE ANALYSIS; RNA EXTRACTION; TRICUSPID VALVE STENOSIS;

ADULT; AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; DNA DAMAGE; FEMALE; HEMODYNAMICS; HUMANS; LEUKOTRIENE C4; MALE; MIDDLE AGED; MITRAL VALVE; OXIDATIVE STRESS; POLY(ADP-RIBOSE) POLYMERASES; SEVERITY OF ILLNESS INDEX; TRANSCRIPTION, GENETIC; TRICUSPID VALVE;

EID: 84859605958     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.03.064     Document Type: Article

References (24)

1. Otto C.M., Kuusisto J., Reichenbach D.D., Gown A.M., O'Brien K.D. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994, 90:844-853.
2. Nagy E., Andersson D.C., Caidahl K., Eriksson M.J., Eriksson P., Franco-Cereceda A., Hansson G.K., Bäck M. Upregulation of the 5-lipoxygenase pathway in human aortic valves correlates with severity of stenosis and leads to leukotriene-induced effects on valvular myofibroblasts. Circulation 2011, 123:1316-1325.
3. Beppu S., Suzuki S., Matsuda H., Ohmori F., Nagata S., Miyatake K. Rapidity of progression of aortic stenosis in patients with congenital bicuspid aortic valves. Am. J. Cardiol. 1993, 71:322-327.
4. Freeman R.V., Otto C.M. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 2005, 111:3316-3326.
5. Liberman M., Bassi E., Martinatti M.K., Lario F.C., Wosniak J., Pomerantzeff P.M., Laurindo F.R. Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification. Arterioscler. Thromb. Vasc. Biol. 2008, 28:463-470.
6. Miller J.D., Chu Y., Brooks R.M., Richenbacher W.E., Pena-Silva R., Heistad D.D. Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans. J. Am. Coll. Cardiol. 2008, 52:843-850.
7. Rajamannan N.M. Bicuspid aortic valve disease: the role of oxidative stress in Lrp5 bone formation. Cardiovasc. Pathol. 2011, 20:168-176.
8. Larsson A.K., Bäck M., Hjoberg J., Dahlen S.E. Inhibition of nitric-oxide synthase enhances antigen-induced contractions and increases release of cysteinyl-leukotrienes in guinea pig lung parenchyma: nitric oxide as a protective factor. J. Pharmacol. Exp. Ther. 2005, 315:458-465.
9. Nie X., Song S., Zhang L., Qiu Z., Shi S., Liu Y., Yao L., Zhu D. 15-Hydroxyeicosatetraenoic acid (15-HETE) protects pulmonary artery smooth muscle cells from apoptosis via inducible nitric oxide synthase (iNOS) pathway. Prostaglandins Other Lipid Mediat. 2012, 97:50-59.
10. Bäck M., Walch L., Norel X., Gascard J.P., Mazmanian G., Brink C. Modulation of vascular tone and reactivity by nitric oxide in porcine pulmonary arteries and veins. Acta Physiol. Scand. 2002, 174:9-15.
11. 2+ induced PARP-1 activation and ANF expression are coupled events in cardiomyocytes. Biochem. J. 2011, 438:337-347.
12. Pacher P., Szabo C. Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease. Am. J. Pathol. 2008, 173:2-13.
13. Toth-Zsamboki E., Horvath E., Vargova K., Pankotai E., Murthy K., Zsengeller Z., Barany T., Pek T., Fekete K., Kiss R.G., Preda I., Lacza Z., Gero D., Szabo C. Activation of poly(ADP-ribose) polymerase by myocardial ischemia and coronary reperfusion in human circulating leukocytes. Mol. Med. 2006, 12:221-228.
14. Virag L., Szabo E., Bakondi E., Bai P., Gergely P., Hunyadi J., Szabo C. Nitric oxide-peroxynitrite-poly(ADP-ribose) polymerase pathway in the skin. Exp. Dermatol. 2002, 11:189-202.
15. Vahanian A., Baumgartner H., Bax J., Butchart E., Dion R., Filippatos G., Flachskampf F., Hall R., Iung B., Kasprzak J., Nataf P., Tornos P., Torracca L., Wenink A. Guidelines on the management of valvular heart disease: the task force on the management of valvular heart disease of the European Society of Cardiology. Eur. Heart J. 2007, 28:230-268.
16. Baumgartner H., Hung J., Bermejo J., Chambers J.B., Evangelista A., Griffin B.P., Iung B., Otto C.M., Pellikka P.A., Quinones M. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur. J Echocardiogr. 2009, 10:1-25.
17. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., Picard M.H., Roman M.J., Seward J., Shanewise J.S., Solomon S.D., Spencer K.T., Sutton M.S., Stewart W.J. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J. Am. Soc. Echocardiogr. 2005, 18:1440-1463.
18. Schroeder A., Mueller O., Stocker S., Salowsky R., Leiber M., Gassmann M., Lightfoot S., Menzel W., Granzow M., Ragg T. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol. Biol. 2006, 7:3.
19. Jian B., Narula N., Li Q.Y., Mohler E.R., Levy R.J. Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis. Ann. Thorac. Surg. 2003, 75:457-465. [discussion 65-6.].
20. Kaden J.J., Dempfle C.E., Grobholz R., Tran H.T., Kilic R., Sarikoc A., Brueckmann M., Vahl C., Hagl S., Haase K.K., Borggrefe M. Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis. Atherosclerosis 2003, 170:205-211.
21. Rajamannan N.M., Gersh B., Bonow R.O. Calcific aortic stenosis: from bench to the bedside-emerging clinical and cellular concepts. Heart 2003, 89:801-805.
22. Helske S., Kupari M., Lindstedt K.A., Kovanen P.T. Aortic valve stenosis: an active atheroinflammatory process. Curr. Opin. Lipidol. 2007, 18:483-491.
23. Cucoranu I., Clempus R., Dikalova A., Phelan P.J., Ariyan S., Dikalov S., Sorescu D. NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ. Res. 2005, 97:900-907.
24. Clark-Greuel J.N., Connolly J.M., Sorichillo E., Narula N.R., Rapoport H.S., Mohler E.R., Gorman J.H., Gorman R.C., Levy R.J. Transforming growth factor-beta1 mechanisms in aortic valve calcification: increased alkaline phosphatase and related events. Ann. Thorac. Surg. 2007, 83:946-953.